Created in 2014 (United States), PIMVEUS own 6 sister brands and 2214 competing brands. The PIMVEUS brand is owned by Acadia Pharmaceuticals, a company listed in New York. PIMVEUS is part of the Biotechnology activity sector.

PIMVEUS is a brand of Acadia Pharmaceuticals (ACAD) Share price

International deposit : 2014 Business sector Biotechnology

Share price and profitability of the share Acadia Pharmaceuticals (PIMVEUS)

Buy Acadia Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 16.99

Portfolio valuation
Acadia Pharmaceuticals (PIMVEUS) over 5 years* USD 11.72

Stock market history Acadia Pharmaceuticals (PIMVEUS)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Acadia Pharmaceuticals

See more brands of Acadia Pharmaceuticals

Rival brands
PIMVEUS

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS